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The Clean Air Act [U.S. Environmental
Protection Agency (EPA) 1970] identiﬁed tro-
pospheric ozone as one of six “criteria pollu-
tants”—pervasive pollutants considered
harmful to human health. Tropospheric ozone
forms as a result of atmospheric reactions of
nitrogen oxides (NOx) and volatile organic
compounds (VOCs) in the presence of sun-
light. Both local emissions sources, such as
trafﬁc, and emissions transported from upwind
sources, such as electric utilities, contribute to
ambient ozone levels in populated areas.
In 1997, the U.S. EPA changed the ozone
standard to 80 ppb to reflect new scientific
studies showing that ozone causes health
effects at levels lower than the previous
120 ppb standard. Additionally, the form of
the standard was changed to reflect studies
showing that exposure times longer than 1 hr
are of concern. The U.S. EPA set the form of
the standard, which is the threshold for com-
pliance and violations, at the fourth highest
daily maximum 8-hr average occurring each
year, averaged over a 3-year period.
New scientiﬁc studies published since 1996
have increased the body of evidence supporting
the association between ambient ozone and a
number of serious health effects (Anderson et al.
2004). For example, studies examining the
association between ambient ozone and prema-
ture mortality have increased the weight of evi-
dence supporting this important health impact
(Anderson et al. 2004; Thurston and Ito 2001).
Our purpose for this analysis was to assess
the human health benefits of attaining the
8-hr ozone standard. We applied a damage
function approach similar to those used in
several recent U.S. EPA regulatory impact
analyses, including those for the proposed
Clean Air Interstate Rule and the ﬁnal Clean
Air Nonroad Diesel Rule (U.S. EPA 2004a,
2004b). We focused the assessment on the
beneﬁts that might have been achieved if cur-
rent monitored ozone levels (represented by
the years 2000–2002) were reduced just to
the levels required to meet the 8-hr standard.
We conducted analyses to examine the sensi-
tivity of our results to a number of different
assumptions about the form of the standard,
background levels of ozone, methods for sim-
ulating attainment of the 8-hr ozone stan-
dard, and the choice of health effects and
effect estimates from published epidemiologic
studies.
In this article, we provide detailed descrip-
tions of the data and methods in this analysis,
along with the results. We describe monitored
ozone levels in 2000, 2001, and 2002, provide
details on how we assigned monitored ozone
levels to populations to estimate population-
level exposures, and outline the two approaches
we used to simulate attainment. We then
discuss the literature on ozone-related health
effects, describe the speciﬁc set of health impact
functions we used in the beneﬁts analysis and
the economic values selected to estimate the
dollar value of ozone-related health impacts,
and discuss how we addressed uncertainty in
the analysis. Finally, we present the results and
implications of the analysis.
Simulation of Changes in
Population-Level Exposures 
to Ambient Ozone Due to
Attainment
Selecting monitoring data. To estimate popu-
lation-level ozone concentrations, we began by
obtaining ozone monitoring data from the
U.S. EPA’s Air Quality System (AQS) (U.S.
EPA 2004c), a database of ambient air pollu-
tion data collected by the U.S. EPA, state,
local, and tribal air pollution control agencies
from > 1,000 monitoring stations across the
country. We analyzed these data using the
Environmental Benefits Mapping and
Analysis Program (BenMAP), developed by
the U.S. EPA for use in estimating the health
impacts and economic beneﬁts associated with
changes in ambient air pollution (you may
obtain a copy of BenMAP by e-mailing a
request to B.J.H.). We used SAS (release 8.02;
SAS Institute Inc., Cary, NC) to process the
AQS data for use in BenMAP.
To characterize ozone levels, we selected
monitors following criteria generally consis-
tent with those the U.S. EPA uses to deter-
mine attainment and nonattainment of the
8-hr standard. We selected monitors that had
a sufﬁcient number of observations during the
ozone “season,” which stretches from 1 May
through 30 September, 153 days. Many areas
of the United States, including Southern
California and Texas, have a longer ozone sea-
son. Accounting for the longer ozone season
in these areas would lead to an increase in the
estimated beneﬁts of attaining the standards.
Because missing monitor observations are
common, we selected only those monitors
that had observations on at least half the days
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During the 2000–2002 time period, between 36 and 56% of ozone monitors each year in the
United States failed to meet the current ozone standard of 80 ppb for the fourth highest maximum
8-hr ozone concentration. We estimated the health beneﬁts of attaining the ozone standard at these
monitors using the U.S. Environmental Protection Agency’s Environmental Beneﬁts Mapping and
Analysis Program. We used health impact functions based on published epidemiologic studies, and
valuation functions derived from the economics literature. The estimated health beneﬁts for 2000
and 2001 are similar in magnitude, whereas the results for 2002 are roughly twice that of each of
the prior 2 years. The simple average of health impacts across the 3 years includes reductions of
800 premature deaths, 4,500 hospital and emergency department admissions, 900,000 school
absences, and > 1 million minor restricted activity days. The simple average of beneﬁts (including
premature mortality) across the 3 years is $5.7 billion [90% conﬁdence interval (CI), 0.6–15.0] for
the quadratic rollback simulation method and $4.9 billion (90% CI, 0.5–14.0) for the proportional
rollback simulation method. Results are sensitive to the form of the standard and to assumptions
about background ozone levels. If the form of the standard is based on the ﬁrst highest maximum
8-hr concentration, impacts are increased by a factor of 2–3. Increasing the assumed hourly back-
ground from zero to 40 ppb reduced impacts by 30 and 60% for the proportional and quadratic
attainment simulation methods, respectively. Key words: air pollution, beneﬁt analysis, health impact
assessment, ozone, standards. Environ Health Perspect 113:73–82 (2005). doi:10.1289/ehp.7186
available via http://dx.doi.org/ [Online 7 October 2004]in this period. Speciﬁcally, each monitor had
to have at least 77 valid days, with a valid day
deﬁned as having at least nine hourly observa-
tions between 0800 and 1950 hr. We did not
use data from any monitor with a parameter
occurrence code (POC) > 4 to avoid errors
that may be introduced by using nonstandard
monitors. (POC codes are used to distinguish
among multiple monitors at the same site that
are measuring the same parameter. In general,
a higher POC code is assigned to monitors
that are not the primary ozone monitor.) For
those locations with more than one ozone
monitor, we selected the monitor with the
lowest POC code (e.g., we chose POC 1
rather than 2), and dropped any others.
Table 1 summarizes the distribution of
monitored fourth highest maximum daily
8-hr average ozone concentrations across the
3 study years. In all years, at least 35% of
monitors failed to meet the level of the stan-
dard. However, there was some variability
between years in the proportion of nonattain-
ment monitors and in the amount by which
monitors exceeded the standard. In 2000 and
2001, < 40% of monitors exceeded the stan-
dard, and ≤ 5% of the monitors exceeded
100 ppb. In 2002, 56% of monitors had
ozone levels that exceeded the standard, and
14% had ozone levels > 100 ppb. Monitored
ozone levels in 2002 were higher in part
because of meteorologic conditions favorable
for ozone formation and transport of ozone
precursors (U.S. EPA 2003).
Ozone concentrations show spatial pat-
terns, with certain areas of the United States,
including California, having consistently high
ozone values from 2000 through 2002. Other
areas, such as the Southeast and Northeast,
varied a great deal across those years. This
may result from differences in climatic vari-
ability, natural phenomena such as wildﬁres,
or differences in ozone precursor (NOx and
VOC) emissions. Year-to-year precursor emis-
sions may vary because of economic cycles;
changes in electricity generation, such as
switching from coal to natural gas; or changes
in vehicle use.
Applying spatial interpolation. Monitor
data represent ambient ozone levels at a series
of discrete points in space. However, beneﬁts
analysis requires an estimate of ambient ozone
concentrations for populations across the
United States. For each year of monitoring
data (2000, 2001, and 2002), we generated
estimates of average ambient ozone levels
for every county in the United States using
applied spatial interpolation methods. Our
base case analysis used Voronoi neighbor
averaging (VNA), an algorithm that estimates
ambient ozone levels by selecting the closest
neighboring monitors surrounding the center
of each county and then calculating the
inverse distance weighted average of the mon-
itor values for the selected neighboring moni-
tors (e.g., Chen et al. 2004; Gold 1997). This
method provides a relatively smooth surface
in densely monitored areas.
We analyzed the accuracy of the VNA
interpolation procedure by dropping individual
monitors and predicting their ambient ozone
levels using the remaining monitors. The
national average differences between predicted
and observed annual averages are < 1% in all
cases, with standard deviations ranging from
10 to 12%. The largest differences occurred in
rural areas and large portions of the western
United States, where few monitors are present;
ozone estimates in these cases are often based
partially on monitors that are quite distant.
Most populations live within 50 km of an
ozone monitor, however, so we can be reason-
ably conﬁdent that estimates of ambient ozone
levels will be acceptable for most populated
areas. We explored the sensitivity of the results
to the choice of spatial interpolation method
by estimating ambient ozone levels using a dis-
tance limited version of VNA (where all moni-
tors farther than 50 km are discarded when
choosing neighbors), as well as using a simple
closest monitor assignment. A detailed expla-
nation of each of these methods is provided in
the Supplemental Material (http://ehp.niehs.
nih.gov/docs/2004/7186/suppl.pdf).
Reducing ozone levels to meet the standard.
To demonstrate the benefits of attaining the
8-hr standard in 2000, 2001, and 2002, we
speciﬁed how ozone levels would be reduced to
bring the speciﬁc attainment “metric” (fourth
highest daily maximum 8-hr average) down to
the level of the standard. The U.S. EPA’s pri-
mary (for health protection) and secondary (for
environmental and welfare protection) 8-hr
ozone standards both are 80 ppb. In determin-
ing attainment and nonattainment, however,
the U.S. EPA must use rounding. As a result,
we consider ozone values ≤ 84 ppb as meeting
the standard.
There are several ways to reduce the dis-
tribution of hourly ozone values to simulate
attainment. For simplicity we treated the
form of the standard as simply the fourth
highest daily maximum 8-hr average, rather
than the fourth highest daily maximum 8-hr
average averaged over the 3 previous years.
We investigated two different methods:
percentage (or proportional) rollback and qua-
dratic rollback. Percentage rollback simply
reduces all daily metric values by the percent-
age required to bring the violating day (the
day with the fourth highest value) down
to 84 ppb. The quadratic rollback method
reduces larger metric values proportionally
more than smaller values.
It is not clear which method provides a
more realistic simulation of an attainment
strategy. If control strategies affect emissions
on all days during the ozone season, then
using percentage rollback may be appropriate.
If control strategies affect emissions on days
with higher ozone levels more than on days
with lower levels, then quadratic rollback may
be more realistic. Both of these approaches
represent implementation strategies that areas
may select to meet the ozone standard. See
Supplemental Material (http://ehp.niehs.
nih.gov/docs/2004/7186/suppl.pdf) for more
details on the two methods.
For both methods, we assume a constant
background 8-hr daily maximum ozone level
of 40 ppb, representing the amount of ozone
(for this averaging period) that is not attri-
butable to U.S. anthropogenic sources. It is
assumed that this background cannot be
affected by attempts to attain the ozone stan-
dards, and thus this portion of the estimated
ambient ozone levels is not adjusted by either
rollback method.
Vingarzan (2004) surveyed recent literature
on background ozone concentrations and con-
cluded that based on data from 1983 to 2001,
median background levels in the United States
ranged between 13 and 47 ppb. Vingarzan
(2004) notes that background levels appear to
be increasing over time because of increased
contributions from international transport of
ozone precursors. Therefore, we selected a
background ozone level toward the upper end
of the observed range because our monitor data
are based on later years. The background level
likely varies across the United States, and our
assumption of 40 ppb adds uncertainty to the
analysis (Vingarzan 2004). We investigated the
impact of different assumptions about back-
ground levels of the attainment metric in a
sensitivity analysis.
Once BenMAP has calculated how the
attainment metric will be affected for each day,
it calculates how the other ozone metrics
required for the various health impact functions
will be affected. These include daily maxima for
1-hr and 8-hr periods, as well as daily averages
over different time periods, including the 24-hr
average, the 5-hr average (1000–1450 hours),
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Table 1. Distribution of fourth highest maximum daily average O3 values across monitors.
Range of Monitors with value in range (%)
O3 values (ppb) 2000 (1,089 monitors) 2001 (1,120 monitors) 2002 (1,146 monitors)
≤ 84 (in attainment) 64 61 44
84–89.9 17 18 15
90–99.9 15 16 27
100–109.9 3 4 11
> 110 1 1 3and the 8-hr average (0900–1650 hours). To
calculate, BenMAP rolls back individual hourly
ozone observations such that they meet the tar-
get metric values. For details on this process,
see Supplemental Material (http://ehp.niehs.
nih.gov/docs/2004/7186/suppl.pdf).
In adjusting individual hourly ozone values
to meet the target metric value, we assumed
that there is no ﬁxed background level of ozone
for any particular hour and set the background
to zero. Any given hourly value may have a
speciﬁc background component; however, we
are unable to determine what this component
might be. We examined the impact of assum-
ing alternative hourly background levels as a
sensitivity analysis.
Finally, BenMAP uses the adjusted hourly
values to calculate the adjusted ozone sum-
mary measures—for example, 24-hr average,
1-hr maximum, and the like. Using the three
methods described above, BenMAP then spa-
tially interpolates the set of adjusted summary
measures to the center of each county. The
differences between the spatially interpolated
baseline and the adjusted summary measures
are the basic air quality inputs to the health
beneﬁts model.
Note that BenMAP does not adjust moni-
tors that meet the attainment test (those with
fourth highest maximum daily 8-hr average
≤ 84 ppb). However, these monitors are
included in the interpolation process, so the
ozone levels assigned to a population in a given
county will, in most cases, reﬂect an average of
monitors with ozone reductions and those with
no reduction. In reality, there will be reduc-
tions in ozone levels at monitors in a non-
attainment area because of controls applied to
meet the standard. Therefore, we are likely
underestimating the change in ambient ozone
that would occur as the result of implementing
attainment strategies.
Health Impact Functions
Health impact functions measure the change in
a health end point of interest, such as hospital
admissions, for a given change in ozone. Health
impact functions are derived from the epidemi-
ology literature. A standard health impact func-
tion has four components: an effect estimate
from a particular epidemiologic study, a baseline
incidence rate for the health effect (obtained
from either the epidemiology study or a source
of public health statistics, e.g., the Centers for
Disease Control and Prevention), the affected
population, and the estimated change in the
relevant ozone summary measures.
A typical health impact function might be
as follows:
∆y = y0 × (eβ • ∆x – 1),
where y0 is the baseline incidence, equal to the
baseline incidence rate times the potentially
affected population; β is the effect estimate;
and ∆x is the estimated change in the summary
ozone measure. There are other functional
forms, but the basic elements remain the same.
The following subsections describe the sources
for each of the elements other than the ozone
air quality inputs to the health impact func-
tions just described: affected populations, effect
estimates, and baseline incidence rates.
Affected Populations
The starting point for estimating affected popu-
lations is the 2000 U.S. Census block-level data
set (Geolytics Inc. 2002). BenMAP incorpo-
rates 250 age/sex/race categories to match spe-
ciﬁc populations potentially affected by ozone
and other air pollutants. The software con-
structs speciﬁc populations matching the popu-
lations in each epidemiologic study by accessing
the appropriate age-speciﬁc populations from
the overall population database. BenMAP pro-
jects populations to 2001 and 2002 using
growth factors based on economic projections
(Woods and Poole Economics Inc. 2001).
Effect Estimate Sources
The most significant benefits of reducing
ambient concentrations of ozone are attribut-
able to reductions in health risks. The U.S.
EPA’s Ozone Criteria Document (U.S. EPA
1996b) and the World Health Organization’s
recent reports (Anderson et al. 2004) outline
numerous health effects known or suspected
to be linked to exposure to ambient ozone.
More than 1,000 new health and welfare
studies have been published since the U.S.
EPA issued the 8-hr ozone standard in 1997.
Many of these studies investigated the impact
of ozone exposure on health effects, such as
changes in lung structure and biochemistry,
lung inﬂammation, asthma exacerbation and
causation, respiratory-illness–related school
absence, hospital and emergency department
(ED) visits for asthma and other respiratory
causes, and premature death.
We excluded some health effects from this
analysis for four reasons: the possibility of
double counting (e.g., hospital admissions for
speciﬁc respiratory diseases), uncertainties in
applying effect relationships that are based on
clinical studies to the affected population, a
lack of an established concentration–response
relationship, or the inability to appropriately
value the effect (e.g., changes in forced expira-
tory volume) in economic terms. Table 2 lists
the health end points included in the primary
and sensitivity analyses for this article.
In selecting epidemiologic studies as
sources of effect estimates, we applied several
criteria to develop a set of studies that is likely
to provide the best estimates of impacts in the
United States. To account for the potential
impacts of different health care systems or
underlying health status of populations, we
gave preference to U.S. studies over non-U.S.
studies. In addition, because of the potential
for confounding by copollutants, we gave
preference to effect estimates from models
including both ozone and particulate matter
over single-pollutant models.
A number of end points that are not health
related also may significantly contribute to
monetized benefits. These include decreased
outdoor worker productivity, decreased yields
for commercial and noncommercial crops,
decreased commercial forest productivity,
damage to urban ornamental plants, impacts
on recreational demand from damaged forest
aesthetics, and damage to ecosystem functions
(U.S. EPA 1996a, 1999). Estimation of these
impacts is beyond the scope of this analysis.
Effect estimates: premature mortality.
Although particulate matter is the air pollutant
most clearly associated with premature mortal-
ity, recent research suggests that repeated ozone
exposure likely contributes to premature death.
Several recent analyses have found consistent
statistical associations between ozone exposure
and increased mortality (Fairley et al. 2003;
Toulomi et al. 1997). In addition, Bell et al.
(2004) found an overall signiﬁcant impact of
ozone on mortality using an extended version
of the National Morbidity, Mortality, and Air
Pollution Study database. Their results were
signiﬁcant even after controlling for PM levels.
Although they do not constitute a data-
base as extensive as that for particulate matter,
these recent studies provide supporting evi-
dence for including mortality in ozone health
benefits analyses. Thurston and Ito (2001)
reviewed previously published time-series
studies examining the effect of daily ozone
levels on daily mortality. They hypothesized
that much of the variability in published esti-
mates of the ozone–mortality effect could be
explained by how well each model controlled
for the influence of weather, an important
confounder, and that earlier studies, which
used less sophisticated approaches to control-
ling for weather, consistently underpredicted
the ozone–mortality effect.
Thurston and Ito (2001) also found that
models incorporating a nonlinear temperature
specification appropriate for the U-shaped
nature of the temperature–mortality relation-
ship (i.e., increased deaths at both very low
and very high temperatures) produced
ozone–mortality effect estimates that were
both more strongly positive (a 2% increase in
relative risk over the pooled estimate for all
studies evaluated) and consistently statistically
signiﬁcant. Further accounting for the inter-
action effects between temperature and rela-
tive humidity strengthened the positive effect.
Including a particulate matter index to control
for particulate matter (PM)–mortality effects
had little effect on these results, suggesting a
relationship between ozone and mortality
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of the studies that Thurston and Ito (2001)
examined controlled only for PM ≤ 10 µm
(PM10) or broader measures of particles and
did not directly control for PM ≤ 2.5 µm
(PM2.5). Therefore, there still may be poten-
tial for confounding of PM2.5 and ozone mor-
tality effects, given that ozone and PM2.5 are
highly correlated during summer months in
some areas.
Two recent World Health Organization
reports found that “recent epidemiologic stud-
ies have strengthened the evidence that there
are short-term O3 effects on mortality and res-
piratory morbidity and provided further infor-
mation on exposure–response relationships
and effect modification” (Anderson et al.
2004; WHO 2003). In addition, Levy et al.
(2001) assessed the epidemiologic evidence
regarding the link between short-term expo-
sures to ozone and premature mortality. Based
on four U.S. studies (Ito and Thurston 1996;
Kelsall et al. 1997; Moolgavkar 2000;
Moolgavkar et al. 1995a), they concluded that
an appropriate pooled effect estimate is a 0.5%
increase in premature deaths per 10 µg/m3
increase in 24-hr average ozone concentrations,
with a 95% conﬁdence interval (CI) between
0.3 and 0.7%.
We included ozone mortality in the base
health effects estimate for the ozone beneﬁts
reanalysis, with the recognition that the exact
magnitude of the effects estimate is subject to
continuing uncertainty. We used results from
three U.S. studies to calculate the base-case
ozone mortality estimate. We selected these
studies (Ito and Thurston 1996; Moolgavkar
et al. 1995a; Samet et al. 1997) based on the
logic that the demographic and environmental
conditions existing when these studies were
conducted would, on average, be most similar
(relative to international studies) to the condi-
tions prevailing when the ozone standards
would be implemented. We examined the
impact of including a fourth U.S. study by
Kinney et al. (1995) in a sensitivity analysis.
We excluded Kinney et al. (1995) from the
primary analysis because, as Levy et al. (2001)
noted, that study included only a linear term
for temperature. Because Kinney et al. (1995)
found no significant ozone effect, including
this study in the primary analysis would lead
to an underestimate of true mortality impacts
and increase the uncertainty surrounding the
estimated mortality reductions.
We then estimated the change in mortality
incidence resulting from application of the
effect estimate from each study and combined
the results using a random-effects weighting
procedure, discussed in the Supplemental
Material (http://ehp.niehs.nih.gov/docs/2004/
7186/suppl.pdf), that accounts for both the
precision of the individual effect estimates and
between-study variability. However, it is impor-
tant to note that this procedure only captures
the uncertainty in the underlying epidemiologic
work and does not capture other sources of
uncertainty, such as that in the estimation of air
pollution exposure (Levy et al. 2001).
Effect estimates: respiratory hospital admis-
sions. Detailed hospital admission and dis-
charge records provide data for an extensive
body of literature examining the relationship
between hospital admissions and air pollution.
This is especially true for the population
≥ 65 years of age, because of the availability of
detailed Medicare records. Because the number
of hospital admission studies is so large, we used
results from a number of studies to pool some
hospital admission end points. In addition,
there is one study (Burnett et al. 2001) provid-
ing an effect estimate for respiratory hospital
admissions in children ≤ 2 years of age.
To estimate total respiratory hospital
admissions associated with changes in ozone for
adults ≥ 65 years of age, we ﬁrst estimated the
change in hospital admissions for the separate
effect categories that each study provided for
each city: Minneapolis, Minnesota; Detroit,
Michigan; Tacoma, Washington; and New
Haven, Connecticut. To estimate all respiratory
hospital admissions for Detroit, we added the
pneumonia and chronic obstructive pulmonary
disease (COPD) estimates, based on the effect
estimates given by Schwartz (1994b). Similarly,
we summed the estimated hospital admissions
based on the effect estimates that Moolgavkar
et al. (1997) reported for Minneapolis. To esti-
mate all respiratory hospital admissions for
Minneapolis using Schwartz (1994a), we sim-
ply estimated pneumonia hospital admissions
based on the effect estimate. Making this
assumption that pneumonia admissions repre-
sent the total impact of ozone on hospital
admissions will give some weight to the possi-
bility that there is no relationship between
ozone and COPD, reflecting the equivocal 
evidence represented by the different studies.
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Table 2. Ozone-related health end points included in primary and sensitivity analyses.
Health effect Applied ages (years) Description Ozone metric
Premature mortality All Pooled estimate
Ito and Thurston (1996) 1-hr daily maximum
Moolgavkar et al. (1995b) 24-hr daily average
Samet et al. (1997) 24-hr daily average
All Sensitivity
WHO (2003) 8-hr average
Respiratory hospital admissions ≥ 65 Pooled estimate
Schwartz (1995): ICD-9 460–519 (all respiratory disease) 24-hr daily average
Schwartz (1994a, 1994b): ICD-9 480–486 (pneumonia)
Moolgavkar et al. (1997): ICD-9 480–487 (pneumonia)
Schwartz (1994b): ICD-9 491–492, 494–496 (COPD)
Moolgavkar et al. (1997): ICD-9 490–496 (COPD)
0 to < 2 Burnett et al. (2001) 24-hr daily average
Asthma-related ED visits All Pooled estimate
Weisel et al. (1995) 5-hr daily average
Cody et al. (1992) 5-hr daily average
Stieb et al. (1996) 24-hr daily average
5–34 Sensitivity
Jaffe et al. (2003) 8-hr daily maximum
Other health effects
School loss daysa Pooled estimate
5–17 Gilliland et al. (2001) 8-hr daily average
5–17 Chen et al. (2000) 1-hr daily maximum
MRADs 18–65 Ostro and Rothschild (1989) 24-hr daily average
COPD, chronic obstructive pulmonary disease.
aGilliland et al. (2001) studied children 9 and 10 years of age. Chen et al. (2000) studied children 6–11 years of age. Based on recent advice from the National Research Council (2002) and
the U.S. EPA Science Advisory Board Health Effects Subcommittee, we have calculated reductions in school absences for all school-age children based on the biologic similarity among
children 5–17 years of age.We then used a ﬁxed-effects pooling procedure
to combine the two all-respiratory hospital-
admission estimates for Minneapolis. Finally,
we used random-effects pooling to combine the
results for Minneapolis and Detroit, in addition
to results for Tacoma and New Haven. As
noted above, this pooling approach accounts
for both the precision of the individual-effect
estimates and the between-study variability
characterizing differences across study locations.
Effect estimate: asthma-related ED visits.
We used three studies as the source for the
concentration–response functions we used to
estimate the effects of ozone exposure on
asthma-related ED visits: Cody et al. (1992),
Weisel et al. (1995), and Stieb et al. (1996). We
estimated the change in ED visits using the
effect estimate from each study and then pooled
the results using the random-effects pooling
procedure described in the Supplemental
Material (http://ehp.niehs.nih.gov/docs/2004/
7186/suppl.pdf). A more recent study by Jaffe
et al. (2003) examined the relationship
between ED visits and air pollution for people
5–34 years of age in the Ohio cities of
Cleveland, Columbus, and Cincinnati from
1991 through 1996. We did not use this partic-
ular study in our primary analysis because it
represents a more limited population and
excludes potentially important impacts on the
population ≥ 35 years of age. However, because
many asthma-related ED visits involve children,
this study was included in a sensitivity analysis
showing the magnitude of results for all ages
relative to those for a population more heavily
weighted toward children. We included both
hospital admissions and ED visits as separate
end points associated with ozone exposure,
because our estimates of hospital admission
costs do not include the costs of ED visits.
Effect estimate sources: minor restricted
activity days. Minor restricted activity days
(MRADs) occur when individuals reduce most
usual daily activities and replace them with less
strenuous activities or rest but do not miss work
or school. We estimated the effect of ozone
on MRADs using a concentration–response
function derived from Ostro and Rothschild
(1989). These researchers estimated the impact
of ozone and PM2.5 on MRAD incidence in a
national sample of the adult working popula-
tion (18–65 years of age) living in metropolitan
areas. We developed separate coefficients for
each year of the Ostro and Rothschild (1989)
analysis (1976–1981), which we then com-
bined for use in the U.S. EPA’s analysis. The
effect estimate used in the impact function is a
weighted average of the coefﬁcients in Ostro
and Rothschild (1989, their Table 4), using the
inverse of the variance as the weight.
Effect estimate: school absences. Children
may be absent from school because of respira-
tory or other acute diseases caused or aggra-
vated by exposure to air pollution. Several
studies have found a significant association
between ozone levels and school absence rates.
We use two recent studies (Chen et al. 2000;
Gilliland et al. 2001) to estimate changes in
school absences resulting from changes in
ozone levels. Gilliland et al. (2001) estimated
the incidence of new periods of absence,
whereas Chen et al. (2000) examined absence
on a given day. We converted the Gilliland
et al. estimate to days of absence by multiply-
ing the absence periods by the average dura-
tion of an absence. We estimated 1.6 days as
the average duration of a school absence, the
result of dividing the average daily school
absence rate from Chen et al. (2000) and
Ransom and Pope (1992) by the episodic
absence rate from Gilliland et al. (2001).
Thus, each Gilliland et al. period of absence is
converted into 1.6 absence days.
Following recent advice from the National
Research Council (2002), we calculated reduc-
tions in school absences for the full population
of school-age children (5–17 years of age).
This is consistent with recent peer-reviewed
literature on estimating the impact of ozone
on school absences (Hall et al. 2003). We esti-
mated the change in school absences using
both Chen et al. (2000) and Gilliland et al.
(2001) and then pooled the results using the




Epidemiologic studies of the association
between pollution levels and adverse health
effects generally provide a direct estimate of
the relationship of air quality changes to the rel-
ative risk of a health effect, rather than estimat-
ing the absolute number of avoided cases.
For example, a typical result might be that a
100 ppb decrease in daily ozone levels might in
turn decrease hospital admissions by 3%. The
baseline incidence of the health effect is neces-
sary to convert this relative change into a num-
ber of cases. A baseline incidence rate is the
estimate of the number of cases of the health
effect per year in the assessment location,
because it corresponds to baseline pollutant lev-
els in that location. To derive the total baseline
incidence per year, this rate must be multiplied
by the corresponding population number. For
example, if the baseline incidence rate is the
number of cases per year per 100,000 people,
that number must be multiplied by the number
of 100,000s in the population.
Table 3 summarizes the sources of baseline
incidence rates and provides average incidence
rates for the end points included in the analysis.
For both baseline incidence and prevalence
data, we used age-speciﬁc rates where available.
We applied concentration–response functions
to individual age groups and then summed over
the relevant age range to provide an estimate of
total population benefits. In most cases, we
used a single national incidence rate, because of
a lack of more spatially disaggregated data.
Whenever possible, the rates used are national
averages, because these data are most applicable
to a national assessment of beneﬁts. For some
studies, however, the only available incidence
information comes from the studies themselves;
in these cases, incidence in the study population
is assumed to represent typical incidence at the
national level. Regional incidence rates are
available for hospital admissions, and county-
level data are available for premature mortality.
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Table 3. National average baseline incidence rates.
Rate per 100 people per year by age group (years)b
End point Sourcea Notes < 18 18–24 25–34 35–44 45–54 55–64 ≥ 65
Mortality CDC compressed mortality ﬁle, nonaccidental, Nonaccidental 0.025 0.022 0.057 0.150 0.383 1.006 4.937
accessed through CDC WONDER (1996–1998)
Respiratory hospital 1999 NHDS public use data ﬁles Incidence 0.043 0.084 0.206 0.678 1.926 4.389 11.629
admissions
Asthma ED visits 2000 NHAMCS public use data ﬁles Incidence 1.011 1.087 0.751 0.438 0.352 0.425 0.232
1999 NHDS public use data ﬁles
MRADs Ostro and Rothschild (1989) Incidence NA 780 780 780 780 780 NA
School loss days U.S. Department of Education (1996) All-cause 990.0 NA NA NA NA NA NA
and 1996 HIS (Adams et al. 1999, Table 47),
estimate of 180 school days per year
Abbreviations: CDC, Centers for Disease Control and Prevention; NA, not applicable.
aThe following abbreviations are used to describe the national surveys conducted by the National Center for Health Statistics: CDC WONDER, CDC Wide-Ranging Online Data for
Epidemiological Research (CDC 2004a); HIS, National Health Interview Survey (CDC 2004b); NHDS, National Hospital Discharge Survey (CDC 2004c); NHAMCS, National Hospital
Ambulatory Medical Care Survey (CDC 2004d). bAll of the rates reported here are population-weighted incidence rates per 100 people per year. Additional details on the incidence and
prevalence rates, as well as the sources for these rates are available upon request.Economic Values for
Health Outcomes
Reductions in ambient concentrations of air
pollution generally lower the risk of future
adverse health effects for a large population.
Therefore, the appropriate economic measure
is willingness to pay (WTP) for changes in
risk of a health effect rather than WTP for a
health effect that would occur with certainty
(Freeman 1993). Epidemiologic studies gener-
ally provide estimates of the relative risks of a
particular health effect that is avoided because
of a reduction in air pollution. We converted
those to units of avoided statistical incidence
for ease of presentation. We calculated the
value of avoided statistical incidences by divid-
ing individual WTP for a risk reduction by the
related observed change in risk. For example,
suppose a pollution-reduction regulation is
able to reduce the risk of premature mortality
from 2 in 10,000 to 1 in 10,000 (a reduction
of 1 in 10,000). If individual WTP for this
risk reduction is $100, then the WTP for an
avoided statistical premature death is $1 million
($100/0.0001 change in risk).
WTP estimates generally are not available
for some health effects, such as hospital admis-
sions. In these cases, we used the cost of treat-
ing or mitigating the effect as a primary
estimate. These cost-of-illness (COI) estimates
generally understate the true value of reducing
the risk of a health effect, because they reﬂect
the direct expenditures related to treatment but
not the value of avoided pain and suffering
(Berger et al. 1987; Harrington and Portney
1987). We provide unit values for health end
points (along with information on the distribu-
tion of the unit value) in Table 4. All values are
in constant year 2000 US$, adjusted for
growth in real income. Economic theory
argues that WTP for most goods (e.g., envi-
ronmental protection) will increase if real
income increases. Many of the valuation stud-
ies used in this analysis were conducted in the
late 1980s and early 1990s. Because real
income has grown since the studies were con-
ducted, people’s WTP for reductions in the
risk of premature death and disease likely has
grown as well. We did not adjust COI-based
values, because they are based on current costs.
Similarly, we did not adjust the value of school
absences, because that value is based on current
wage rates. Table 4 presents the values for
individual end points adjusted to year 2000
income levels.
Mortality. To estimate the monetary bene-
ﬁt of reducing the risk of premature death, we
used the “value of statistical lives” saved (VSL)
approach, which is a summary measure for the
value of small changes in mortality risk for a
large number of people. The VSL approach
applies information from several published
value-of-life studies to determine a reasonable
monetary value of preventing premature mor-
tality. The mean value of avoiding one statisti-
cal death is estimated to be roughly $6 million
in 2000 US$. This represents an intermediate
value from a variety of estimates in the eco-
nomics literature (U.S. EPA 1999).
Respiratory hospital admissions. In the
absence of estimates of societal WTP to avoid
hospital visits/admissions for speciﬁc illnesses,
estimates of total COI (total medical costs
plus the value of lost productivity) typically
are used as conservative, or lower bound, esti-
mates. These estimates are biased downward
because they do not include the WTP value
of avoiding pain and suffering.
The International Classiﬁcation of Diseases,
9th Revision (ICD-9; International Classiﬁcation
of Diseases 1979) code-speciﬁc COI estimates
we used in this analysis consist of estimated hos-
pital charges and the estimated opportunity cost
of time spent in the hospital (based on the aver-
age length of a hospital stay for the illness). We
based all estimates of hospital charges and length
of stays on statistics provided by the Agency for
Healthcare Research and Quality (2000). We
estimated the opportunity cost of a day spent in
the hospital as the value of the lost daily wage,
regardless of whether the hospitalized individual
is in the workforce. To estimate the lost daily
wage, we divided the 1990 median weekly wage
by 5 and inﬂated the result to 2000 US$ using
the urban consumer price index (CPI-U) (U.S.
Bureau of Labor Statistics 2004) for “all items.”
The resulting estimate is $109.35. The total
COI estimate for an ICD code–speciﬁc hospital
stay lasting n days, then, was the mean hospital
charge plus $109 ×n.
Asthma-related ED visits. To value asthma
ED visits, we used a simple average of two esti-
mates from the health economics literature.
The first estimate comes from Smith et al.
(1997), who reported approximately 1.2 mil-
lion asthma-related ED visits in 1987, at a total
cost of $186.5 million (1987 US$). The aver-
age cost per visit that year was $155; in 2000
US$, that cost was $311.55 (using the CPI-U
for medical care to adjust to 2000 US$). The
second estimate comes from Stanford et al.
(1999), who reported the cost of an average
asthma-related ED visit at $260.67, based on
1996–1997 data. A simple average of the two
estimates yields a (rounded) unit value of $286.
Minor restricted activity days. No studies
are reported to have estimated WTP to avoid
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Table 4. Unit values for economic valuation of health end points (2000 US$).
Mean estimate adjusted for
Health end point Description income growth to 2000a Distribution
Mortality VSL based on 26 $6.5 million per The $6.5 million estimate is the mean of a Weibull distribution ﬁtted to the estimates from
studies statistical life 26 value-of-life studies identiﬁed in U.S. EPA section 812 reports (e.g., U.S. EPA 1999) as
“applicable to policy analysis.” Five of the 26 studies are contingent valuation studies, which
directly solicit WTP information from surveyed subjects. The remainder are
wage-risk studies, which base WTP estimates on estimates of the additional compensation
demanded for riskier jobs.
Hospital admissions All respiratory, $18,353 per admission No distributions available. The COI point estimates (lost earnings plus direct medical
≥ 65 years of age costs) are based on ICD-9 code-level information (e.g., average hospital care costs, average
length of hospital stay, and weighted share of total COPD category illnesses) reported in Agency
for Healthcare Research and Quality (2000).
All respiratory, $7,741 per admission
0 to < 2 years of age
ED visits Asthma-related $286 per visit No distribution available. The COI point estimate is the simple average of two unit COI
values: $312 from Smith et al. (1997), and $261 from Stanford et al. (1999).
Minor effects MRAD $52 per day Median WTP estimate to avoid one MRAD from Tolley et al. (1986). Distribution is assumed to
be triangular with a minimum of $22 and a maximum of $83. Range is based on assumption that
value should exceed WTP for a single mild symptom (the highest estimate for a single symptom
—for eye irritation—is $16.00) and be less than that for a work loss day. The triangular
distribution acknowledges that the actual value is likely to be closer to the point estimate than
either extreme.
School absences $75 per day No distribution available.
aThe derivation of each of the estimates is discussed in the text. COI-based unit values are not adjusted for income growth because they are based on current costs and wage rates.
These include hospital admissions, ED visits, and school absences.an MRAD. However, Industrial Economics
Inc. (unpublished data) has derived an estimate
of WTP to avoid a minor respiratory restricted
activity day, using estimates from Tolley et al.
(1986) of WTP for avoiding a combination of
coughing, throat congestion, and sinusitis. The
IEc estimate of WTP to avoid a minor respira-
tory restricted activity day is $38.37 (1990
US$), or about $52 (2000 US$).
Although Ostro and Rothschild (1989)
statistically linked ozone and MRADs, it is
likely that most MRADs associated with
ozone exposure are, in fact, minor respiratory
restricted activity days. For the purpose of
valuing this health end point, we used the
estimate of mean WTP to avoid a minor res-
piratory restricted activity day.
School absences. To value a school
absence, we a) estimated the probability that if
a school child stays home from school, a par-
ent will have to stay home from work to care
for the child; and b) valued the lost productiv-
ity at the parent’s wage. To do this, we esti-
mated the number of families with school-age
children in which both parents work, and we
valued a school-loss day as the probability that
such a day also would result in a work-loss
day. We calculated this value by multiplying
the proportion of households with school-age
children by a measure of lost wages.
We used this method in the absence of
a preferable WTP method. However, this
approach is likely to understate the value of
school-loss days in three ways: First, it omits
WTP to avoid the symptoms/illness that
resulted in the school absence; second, it effec-
tively gives zero value to school absences that
do not result in work-loss days; and third, it
uses conservative assumptions about the wages
of the parent staying home with the child.
For this valuation approach, we assumed
that in a household with two working par-
ents, the female parent will stay home with a
sick child. From the Statistical Abstract of the
United States (U.S. Census Bureau 2001), we
obtained a) the numbers of single, married,
and “other” (widowed, divorced, or sepa-
rated) working women with children; and
b) the rates of participation in the workforce
of single, married, and “other” women with
children. From these two sets of statistics, we
calculated a weighted average participation
rate of 72.85%.
Our estimate of daily lost wage (wages lost
if a mother must stay at home with a sick child)
is based on the year 2000 median weekly wage
among women ≥ 25 or more years of age (U.S.
Census Bureau 2001). This median weekly
wage is $551. Dividing by 5 gives an estimated
median daily wage of $103. To estimate the
expected lost wages on a day when a mother has
to stay home with a school-age child, we ﬁrst
estimated the probability that the mother is in
the workforce and then multiplied that estimate
by the daily wage she would lose by missing a




Any complex analysis is likely to reﬂect many
sources of uncertainty, and this analysis is
no exception. We used numerous inputs to
derive the beneﬁts estimate, including meas-
ured ozone concentrations at monitor sites,
interpolation methods, estimates of values
(both from WTP and COI studies), popula-
tion estimates, baseline incidence rate esti-
mates, and income estimates. Each of these
inputs may be uncertain, and depending on
its location in the beneﬁts analysis, each may
have a disproportionately large impact on
ﬁnal estimates of total beneﬁts. For example,
we used measured ozone concentrations at
monitor sites in the ﬁrst stage of the analysis,
meaning that any uncertainty in those meas-
urements will propagate as the analysis con-
tinues. When compounded with uncertainty
in later stages of analysis, even small uncer-
tainties in monitored ozone levels can lead to
large impacts on total beneﬁts.
Given the wide variety of sources for
uncertainty and the potentially large degree of
uncertainty about any specific estimate, we
characterized uncertainty in two ways, using
both a limited scope Monte Carlo analysis and
sensitivity analyses.
More than one source of uncertainty usu-
ally exists, even for individual end points. This
makes it difﬁcult to provide an overall quanti-
ﬁed uncertainty estimate, for either individual
end points or total beneﬁts. For example, the
health impact function used to estimate
avoided premature deaths has an associated
standard error that represents the statistical
error around the effect estimate in the under-
lying epidemiologic study. In our results,
we report a CI based on this standard error,
reflecting the uncertainty in the estimated
change in incidence of avoided premature
deaths. However, this CI omits the contribu-
tion of air quality changes, baseline incidence
rates, populations exposed, and transferability
of the effect estimate to diverse locations. As a
result, the reported CI gives a potentially mis-
leading picture about the overall uncertainty
in the estimates. This information should be
interpreted within the context of the larger
uncertainty surrounding the entire analysis.
We used Monte Carlo methods to gener-
ate CIs around the estimated health impact
and dollar benefits. Monte Carlo simulation
uses random sampling from distributions of
parameters to characterize the effects of uncer-
tainty on output variables, such as incidence
of premature mortality. Distributions for indi-
vidual effect estimates are based on the
reported standard errors in the epidemiologic
studies. Distributions for unit values are
described in Table 4.
Results and Implications
Table 5 summarizes the incidence and valua-
tion for each year associated with two attain-
ment simulation methods, percentage and
quadratic. Table 6 provides the results aver-
aged across the 3 years. In addition to the
mean incidence and valuation estimates, we
have included a 5th and 95th percentile esti-
mate in Table 6, based on the Monte Carlo
simulations described above. To calculate the
air quality values under each attainment sce-
nario, we rolled back the ozone monitor data
so that the fourth highest daily maximum
8-hr average just met the level required to
attain the standard. This approach will likely
understate the benefits that would occur
because of implementation of actual controls
to reduce ozone precursor emissions. These
controls would likely reduce ozone concentra-
tions at all monitors within a nonattainment
area, rather than just at those monitors with
out-of-attainment ozone values. Therefore,
our results are an underestimate of the likely
beneﬁts of attaining the ozone standard. In all
of the primary analytical cases, we used VNA
with no distance limit and assumed a 40 ppb
background level for the attainment metric
and an hourly background level of zero.
The results for 2000 and 2001 are similar
in magnitude, whereas the results for 2002 are
roughly twice that of each of the prior 2 years.
The simple average of beneﬁts (including pre-
mature mortality) across the 3 years is $5.7 bil-
lion (90% CI, 0.6–15.0) for the quadratic
rollback simulation method and $4.9 billion
(90% CI, 0.5–14.0) for the percentage roll-
back simulation method. Average benefits
without premature mortality are $200 million
(90% CI, 72–350) for the quadratic rollback
method and $160 million (90% CI, 65–310)
for the percentage rollback method. Including
premature mortality in our estimates had the
largest impact on the overall magnitude of ben-
eﬁts: Premature mortality beneﬁts account for
more than 95% of the total benefits we can
monetize.
Table 7 shows the impact on incidence of
health impacts of a range of assumptions
regarding how we rolled back the ozone moni-
tor values. We considered the impact of ordi-
nality—that is, of choosing the ﬁrst versus the
fourth highest daily maximum 8-hr average—
and we chose a range of alternative background
levels. Regardless of attainment simulation
method, ordinality had the largest apparent
impact, with roughly a factor of 2–3 separating
results between the first highest and fourth
highest 8-hr maximum. It is important to note
that health impacts are likely to occur when-
ever the 8-hr daily maximum is elevated, not
just when the number of exceedances is greater
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underlying health science and seeks to protect
public health, it does not guarantee zero health
impacts. That said, the magnitude of the differ-
ence in this analysis is still somewhat surprising.
Two elements contribute to this result.
First, certain monitors will meet the standard
with an ordinality of four but will not meet
the standard with an ordinality of one. That
is, some monitors may have one metric value
> 84 ppb but will not have four such values.
As discussed above, monitors that meet the
standard are not adjusted at all, so these mon-
itors will have a large impact on the results.
Second, certain monitors have a small num-
ber of outlier metric values that are much
higher than all of the rest. Because the roll-
back strategies both adjust all metric values,
basing a rollback on these outlier values can
cause much higher reductions across the
entire year.
The impact of attainment metric back-
ground and the hourly background depended
on attainment simulation method. Under the
percentage rollback attainment simulation
method, shifting the attainment metric back-
ground from 40 to 0 increased impacts by
roughly a factor of 2, but the same shift under
the quadratic rollback method had no signiﬁ-
cant impact on results. However, shifting the
hourly background level from 0 to 40 under
the quadratic rollback method resulted in a
roughly 60% reduction in impacts, while
making the same background shift using the
percentage rollback method reduced impacts
by around a third.
For any particular assumption of back-
ground ozone levels, our estimates are likely
to understate the actual benefits that would
occur from implementing control strategies
to attain the 8-hr standard, because of our
assumption that only the specific monitors
that are out of attainment in any area will
realize reductions in ozone levels. Our esti-
mates of beneﬁts in areas of the country with
longer ozone seasons, such as California and
Texas, will also be underestimates due to our
assumption of a fixed ozone season from
1 May to 30 September for the entire nation.
Analyses of specific attainment strategies
should allow for changes in ambient ozone
across all monitors in a nonattainment area,
as well as accounting for the variable length of
the ozone season. Because there is currently
no known threshold for most ozone-related
health effects, there is likely to be a signiﬁcant
benefit to reducing ozone concentrations
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Table 5. Summary of estimated annual health beneﬁts of attaining the 8-hr standard.
2000 2001 2002
End point Cases Economic valuea Cases Economic valuea Cases Economic valuea
Quadratic rollback
Premature mortality 560 3,600 670 4,400 1,300 8,400
Hospital admissions, respiratory, adults 1,500 27 1,900 34 3,600 67
Total hospital admissions, respiratory, children 1,700 13 1,600 13 2,900 23
ED visits for asthma 370 0.11 410 0.12 750 0.22
School absences 740,000 55 780,000 59 1,400,000 110
MRADs 950,000 49 1,100,000 55 2,000,000 100
Total economic value of health changes
With premature mortality 3,700 4,600 8,700
Without premature mortality 140 160 300
Percentage rollback
Premature mortality 500 3,200 590 3,300 1,160 7,600
Hospital admissions, respiratory, adults 1,300 24 1,600 17 3,200 60
Total hospital admissions respiratory, children 1,500 12 1,500 3 2,700 21
ED visits for asthma 330 0.10 360 0.05 680 0.20
School absences 660,000 50 700,000 27 1,300,000 97
MRADs 850,000 44 950,000 18 1,800,000 93
Total economic value of health changes
With premature mortality 3,300 3,400 7,900
Without premature mortality 130 70 270
aMillion (2000 US$).
Table 6. Estimated average annual health beneﬁts of attaining 8-hr standard (2000–2002 monitor data).
Age Cases Economic value (million 2000 US$)
Endpoint range (years) 5th Mean 95th 5th Mean 95th
Quadratic rollback
Premature mortality All 290 840 1,600 500 5,500 15,000
Hospital admissions, respiratory, adults ≥ 65 530 2,300 4,600 10 43 84
Total hospital admissions, respiratory, children 0 to < 2 1,100 2,100 3,100 8.70 16 24
ED visits for asthma All 180 510 870 0.05 0.15 0.26
School absences 5–17 350,000 970,000 1,700,000 26 75 130
MRADs 18–64 670,000 1,400,000 2,000,000 28 68 110
Total economic value of health changes
With premature mortality 570 5,700 15,000
Without premature mortality 70 200 350
Percentage rollback
Premature mortality All 260 750 1,400 470 4,700 13,000
Hospital admissions, respiratory, adults ≥ 65 470 2,000 4,100 8.70 34 76
Total hospital admissions, respiratory, children 0 to < 2 970 1,900 2,800 7.70 12 22
ED visits for asthma All 150 460 770 0.04 0.12 0.23
School loss days 5–17 310,000 890,000 1,500,000 23 58 120
MRADs 18–64 610,000 1,200,000 1,800,000 26 52 110
Total economic value of health changes
With premature mortality 530 4,900 14,000
Without premature mortality 65 160 310
5th and 95th percentile estimates based on the Monte Carlo simulations described in the text.beyond the standard at monitors that cur-
rently attain the standard.
Applying a distance limit of 50 km to the
VNA method reduced benefits by 3–10%,
depending on the year of analysis. Use of a
closest monitor algorithm with a 50-km limit
reduced benefits by 10–15%, depending on
the year of analysis. Most of this difference
occurs because approximately 10% of the
population lives > 50 km away from an ozone
monitor. Detailed sensitivity analyses examin-
ing the choice of interpolation method are
available on request.
Our estimates of mortality-related beneﬁts
of attaining the standards may change, based
on emerging meta-analyses of the ozone mor-
tality literature. If these meta-analyses conﬁrm
the results of Thurston and Ito (2001), Levy
et al. (2001), or the WHO report (2003)
meta-analyses, the mean mortality benefits
may increase by a factor of 2, suggesting that
reductions in premature mortality associated
with attainment of the ozone standards might
be as high as 1,600 premature deaths avoided
annually. This increase would substantially
increase the economic value of health impacts
as well, potentially up to $10 billion. Using
the Jaffe et al. (2003) effect estimates for
asthma ED visits in the population 5–34 years
of age would have increased the estimated
number of avoided admissions by approxi-
mately 4.5 times. This suggests that the all-
ages estimates based on earlier studies may
underestimate impacts in younger popula-
tions. Details of the sensitivity analyses exam-
ining alternative mortality and morbidity
effect estimates are available from the authors.
In this analysis we estimated the health
beneﬁts of reducing ozone levels in areas with
monitored values that exceed the 8-hr ozone
standard. The increasing need to understand
the public health impacts of air pollution reg-
ulations requires the merging of models and
data from many disciplines. Although neces-
sary, this type of multidisciplinary methodol-
ogy is challenging in complexity and scope.
Our approach illustrates the integration of
models and data and highlights uncertainties
inherent in the end results. The result sug-
gests there may be signiﬁcant health beneﬁts
arising from actions that reduce ozone con-
centrations in nonattainment areas.
The results of our analysis suggest that mov-
ing from current monitored ozone levels to full
attainment of the 8-hr standard may yield sub-
stantial health beneﬁts. We estimate total bene-
ﬁts (including premature mortality) of meeting
the standard as reaching up to $5.7 billion (aver-
aged over 3 years, 2000–2002). These dollar
benefits are associated with average annual
reductions in health effects, including > 800
avoided premature deaths, > 4,000 avoided hos-
pital admissions, approximately 500 avoided
asthma ED visits per year, > 1 million avoided
restricted activity days, and > 900,000 avoided
school absences.
We provide sensitivity analyses to examine
key modeling assumptions. In addition, we
could not quantify other uncertainties, such as
the importance of unquantified effects and
uncertainties in the interpolation of ambient
air quality. Inherent in any analysis of health
impacts are uncertainties in affected popula-
tions, health baselines, incomes, effect esti-
mates, and other factors. The assumptions
used to capture these elements are reasonable
based on the available evidence. However,
these data limitations prevent a full-scale
quantitative estimate of the uncertainty associ-
ated with estimates of total economic beneﬁts.
If one is mindful of these limitations, the mag-
nitude of the beneﬁt estimates presented here
can be useful information in expanding the
understanding of the public health impacts of
attaining the 8-hr ozone standard.
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